Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 382.00
Bid: 374.00
Ask: 384.00
Change: 12.00 (3.24%)
Spread: 10.00 (2.674%)
Open: 382.00
High: 382.00
Low: 382.00
Prev. Close: 370.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Jul 2009 07:00

RNS Number : 2015V
Microgen PLC
07 July 2009
 



microgen

www.microgen.com

 7 July 2009

M icrogen plc

Trading Update

Microgen plc ('Microgen' or 'the Group'provides an update on trading ahead of the Group's Interim Results, for the six months ended 30 June 2009, which are anticipated to be released in late July. 

During the first half of 2009, Microgen Aptitude Solutions Division ("MASD") has seen considerable success. In addition to the multi-million pound contract reported in the April Interim Management Statementthe division is also now engaged on three significant new customer projects :

Major UK Bank : MASD has recently signed a contract for Microgen Accounting Hub and Microgen Aptitude. This project is anticipated to produce revenue in excess of £1 million in the coming year.

US Manufacturer : In parallel with final contract negotiations, MASD is commencing the initial design phase of a project for Microgen Aptitude which is also anticipated to produce revenue in excess of £1 million in the coming year.

Major US Financial Institution : MASD is currently undertaking a significant customer-funded proof-of-concept which may or may not lead to a major contract for Microgen Aptitude and/or Microgen Accounting Hub.

As a result of these projects and additional prospects, the Board anticipates MASD delivering a strong second half of the year. The operating loss for MASD in the first-half has significantly reduced compared to the prior year. Microgen expenses all development costs as incurred and has no R&D capitalisation on its balance sheet. This results in a high correlation between operating income and cash flow for the Group as a whole and, as the revenue increases within MASD, profitability of this division should scale accordingly.

As anticipated, the Group's Billing Services Division and Financial Systems Division have reflected the economic climate but are trading in line with the Board's expectations. These divisions have high recurring revenue and hence remain profitable, high margin businesses with strong cash flow.

Cash at 30 June 2009 was £15.2 million, compared to £14.7 million at 31 December 2008, after repayment of £1.3 million of the loan associated with the freehold property and payment of the final dividend of £1.2 million.

Overall, despite the continuing difficult market environment, the first half of 2009 is anticipated to be in line with the Board's expectations, but, as a result of the strong MASD performance, and subject to contracts being finalised for the two projects noted aboveearnings for the year are anticipated to be ahead of current market expectations.

Contacts

Martyn Ratcliffe, Chairman

01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

Giles Sanderson, Financial Dynamics

Haya Chelhot, Financial Dynamics

020-7831-3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBSGDRXXGGGCL
Date   Source Headline
12th Aug 20194:46 pmRNSHolding(s) in Company
7th Aug 20195:43 pmRNSHolding(s) in Company
6th Aug 201912:56 pmRNSDirector/PDMR Shareholding and Total Voting Rights
1st Aug 20197:00 amRNSTotal Voting Rights
30th Jul 20193:20 pmRNSBlock Listing Application
24th Jul 20197:00 amRNSInterim Results
15th Jul 20197:00 amRNSTrading Update, Board Changes & Notice of Results
12th Jul 20194:53 pmRNSHolding(s) in Company
28th Jun 20191:27 pmRNSCompletion of sale of Microgen Financial Systems
24th Jun 20194:40 pmRNSSecond Price Monitoring Extn
24th Jun 20194:35 pmRNSPrice Monitoring Extension
24th Jun 20191:14 pmRNSResult of General Meeting
5th Jun 20195:47 pmRNSPublication of Circular and Notice of GM
5th Jun 20191:45 pmRNSHolding(s) in Company
3rd Jun 20194:36 pmRNSHolding(s) in Company
3rd Jun 20198:24 amRNSTotal Voting Rights
30th May 20197:00 amRNSProposed sale of Microgen Financial Systems
22nd May 20195:02 pmRNSHolding(s) in Company
21st May 20192:47 pmRNSResult of AGM
21st May 20197:00 amRNSAGM Trading & Demerger Update
1st May 20197:00 amRNSTotal Voting Rights
30th Apr 20196:23 pmRNSHolding(s) in Company
2nd Apr 201912:12 pmRNSChange of Name to Aptitude Software Group plc
1st Apr 201911:04 amRNSTotal Voting Rights
27th Mar 20197:00 amRNSCorrection - Dividend Payment Schedule
26th Mar 20197:00 amRNSBLOCK LISTING 6-MONTHLY RETURN
25th Mar 20197:01 amRNSStrategic Update
25th Mar 20197:00 amRNSFinal Results
12th Mar 20197:00 amRNSNotice of Preliminary Results
1st Feb 20197:00 amRNSTotal Voting Rights
18th Jan 20192:12 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSTrading Update and Notice of Results
6th Dec 20185:13 pmRNSHolding(s) in Company
3rd Dec 201812:00 pmRNSTotal Voting Rights
30th Oct 20187:00 amRNSTrading Update
27th Sep 20182:54 pmRNSBlock Listing Six Monthly Return
5th Sep 201811:58 amRNSHolding(s) in Company
4th Sep 20184:29 pmRNSBlock Listing Application
31st Aug 201810:17 amRNSAward of Options
30th Jul 20188:21 amRNSHolding(s) in Company
25th Jul 201811:30 amRNSHolding(s) in Company
23rd Jul 20187:00 amRNSInterim Results
20th Jul 201811:19 amRNSHolding(s) in Company
17th Jul 20187:00 amRNSNotice of Interim Results
9th Jul 20187:00 amRNSTotal Voting Rights
3rd Jul 201812:21 pmRNSHolding(s) in Company
3rd Jul 201812:04 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSDisposal of Payments Business
2nd Jul 20189:50 amRNSDirector Declaration
18th Jun 20181:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.